Page last updated: 2024-08-23

1-carboxyglutamic acid and Osteoporosis, Postmenopausal

1-carboxyglutamic acid has been researched along with Osteoporosis, Postmenopausal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, XP; Diez-Perez, A; Ekangaki, A; Harpe, K; Huang, QR; Li, HL; Liu, H; Liu, JL; Liu, YJ; Lu, JH; Qin, YJ; Wei, DL; Zhang, Y; Zhang, ZL; Zheng, YM; Zhu, HM1

Trials

1 trial(s) available for 1-carboxyglutamic acid and Osteoporosis, Postmenopausal

ArticleYear
[Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Zhonghua yi xue za zhi, 2004, Feb-17, Volume: 84, Issue:4

    Topics: 1-Carboxyglutamic Acid; Absorptiometry, Photon; Aged; Bone Density; Collagen; Collagen Type I; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Estrogen Antagonists; Female; Humans; Lipids; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Pelvic Bones; Peptides; Raloxifene Hydrochloride; Treatment Outcome

2004